Issuers, get 33% more new shareholders with investorHub. Learn more
Learn
Looking for more information?
Contact our responsive and friendly client services team any time.
Current price
$0.57
▾0.01 (1.79%)
Last trade: 10/06, 6:36AM
Market cap
$101.61m
Market closed
Talk to Recce Pharmaceuticals Ltd directly.
Sign up to their Investor Hub for direct access to the Recce Pharmaceuticals Ltd team, ask them questions, and see personal updates.
Investor Presentations
Principal Activity
Recce Pharmaceuticals Ltd (ASX:RCE) is an Australian based globally-focussed, biotechnology company engaged in the development and commercialisation of a new class of antibiotics. RCE's portfolio of antibiotic therapies seek to address health threats posed by drug resistant bacteria. Their lead candidate RECCE®327 is designed as abroad-spectrum antibiotic, formulated using synthetic polymer technology to treat bacterial sepsis (blood poisoning) and other bacterial infections, including superbugs.
Address
Level 36, Gateway, 1 Macquarie Pl, Sydney NSW 2000, Australia
Website
News
Announcements
Filter
| Announcement | T+2 Movement | Date |
|---|---|---|
Market Data
Day
3m
1yr
5yr
Current price
$0.57
Open price
-
Day low-high
-
Price change
Percent change
Previous close
-
Volume
-
Turnover
-
Bid price
-
Ask price
-
Market cap
-
Shares outstanding
-
Year high
-
Year low
-
Year low-high
-
Earnings per share
-
Price/earnings ratio
-
Dividend yield
-
Dividend per share
-
Franking
-
Investor Presentations
News
Sector Peers
| Company | Market Cap | ||
|---|---|---|---|
Support
Live Chat
Markets
Contact Us
(03) 9661 0441
clients@freshequities.com
Address
Level 16, 452 Flinders St
Melbourne VIC 3000
Australia